CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 294 enrolled
Drug / intervention
Biofinity Multifocal D +1.50 add +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02255474
NCT02255474N/ACompleted
CompareCT.gov

Soft Bifocal Contact Lens Myopia Control

Ohio State University·interventional·Posted Oct 2, 2014·Updated Mar 10, 2021

In Brief

A clinical study evaluating Biofinity Multifocal D +1.50 add, Biofinity Multifocal D +2.50 add, and 1 other intervention for Refractive Errors. Completed, enrolled 294 participants across 2 sites.

Detailed Summary

This study will evaluate the use of two different bifocal contact lens add powers to prevent further nearsighted progression in children ages 7 to 11 years old. It is theorized that the profile of the bifocal lenses will decrease the amount of change in nearsightedness that the children experience.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRefractive Errors
CountriesUnited States
CollaboratorsUniversity of Houston, National Eye Institute (NEI)

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 2, 2014
Enrollment StartSep 22, 2014
Primary CompletionJun 24, 2019
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 11.8 years ago

Interventions

Biofinity Multifocal D +1.50 adddevice

This is a monthly disposable contact lens commercially available from CooperVision

Biofinity Multifocal D +2.50 adddevice

This is a monthly disposable contact lens commercially available from CooperVision

Biofinitydevice

This is a monthly disposable spherical contact lens commercially available from CooperVision